Literature DB >> 24064459

Cofactoring and dimerization of proteinase-activated receptors.

Huilan Lin1, Allen P Liu, Thomas H Smith, JoAnn Trejo.   

Abstract

Proteinase-activated receptors (PARs) are G protein-coupled receptors that transmit cellular responses to extracellular proteases and have important functions in vascular physiology, development, inflammation, and cancer progression. The established paradigm for PAR activation involves proteolytic cleavage of the extracellular N terminus, which reveals a new N terminus that functions as a tethered ligand by binding intramolecularly to the receptor to trigger transmembrane signaling. Most cells express more than one PAR, which can influence the mode of PAR activation and signaling. Clear examples include murine PAR3 cofactoring of PAR4 and transactivation of PAR2 by PAR1. Thrombin binds to and cleaves murine PAR3, which facilitates PAR4 cleavage and activation. This process is essential for thrombin signaling and platelet activation, since murine PAR3 cannot signal alone. Although PAR1 and PAR4 are both competent to signal, PAR1 is able to act as a cofactor for PAR4, facilitating more rapid cleavage and activation by thrombin. PAR1 can also facilitate PAR2 activation through a different mechanism. Cleavage of the PAR1 N terminus by thrombin generates a tethered ligand domain that can bind intermolecularly to PAR2 to activate signaling. Thus, PARs can regulate each other's activity by localizing thrombin when in complex with PAR3 and PAR4 or by cleaved PAR1, providing its tethered ligand domain for PAR2 activation. The ability of PARs to cofactor or transactivate other PARs would necessitate that the two receptors be in close proximity, likely in the form of a heterodimer. Here, we discuss the cofactoring and dimerization of PARs and the functional consequences on signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24064459      PMCID: PMC3799237          DOI: 10.1124/pr.111.004747

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  94 in total

1.  Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization.

Authors:  M J Shapiro; J Trejo; D Zeng; S R Coughlin
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

2.  Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization.

Authors:  Joseph N McLaughlin; Myla M Patterson; Asrar B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

3.  Protease-activated receptor 3 is a second thrombin receptor in humans.

Authors:  H Ishihara; A J Connolly; D Zeng; M L Kahn; Y W Zheng; C Timmons; T Tram; S R Coughlin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

4.  Ligand cross-reactivity within the protease-activated receptor family.

Authors:  B D Blackhart; K Emilsson; D Nguyen; W Teng; A J Martelli; S Nystedt; J Sundelin; R M Scarborough
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

5.  Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode.

Authors:  J Chen; M Ishii; L Wang; K Ishii; S R Coughlin
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

6.  'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.

Authors:  Nicole C Kaneider; Andrew J Leger; Anika Agarwal; Nga Nguyen; George Perides; Claudia Derian; Lidija Covic; Athan Kuliopulos
Journal:  Nat Immunol       Date:  2007-10-28       Impact factor: 25.606

7.  Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting.

Authors:  Ali Salahpour; Stéphane Angers; Jean-François Mercier; Monique Lagacé; Stefano Marullo; Michel Bouvier
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

8.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

9.  G13 is an essential mediator of platelet activation in hemostasis and thrombosis.

Authors:  Alexandra Moers; Bernhard Nieswandt; Steffen Massberg; Nina Wettschureck; Sabine Grüner; Ildiko Konrad; Valerie Schulte; Barsom Aktas; Marie-Pierre Gratacap; Melvin I Simon; Meinrad Gawaz; Stefan Offermanns
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

10.  Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.

Authors:  Meritxell Canals; Daniel Marcellino; Francesca Fanelli; Francisco Ciruela; Piero de Benedetti; Steven R Goldberg; Kim Neve; Kjell Fuxe; Luigi F Agnati; Amina S Woods; Sergi Ferré; Carme Lluis; Michel Bouvier; Rafael Franco
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

View more
  43 in total

1.  Characterization of thrombin-bound dabigatran effects on protease-activated receptor-1 expression and signaling in vitro.

Authors:  Buxin Chen; Antonio G Soto; Luisa J Coronel; Ashley Goss; Joanne van Ryn; JoAnn Trejo
Journal:  Mol Pharmacol       Date:  2015-05-01       Impact factor: 4.436

2.  Protease Activity in Vascular Disease.

Authors:  Megan A Slack; Scott M Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-25       Impact factor: 8.311

3.  Noncanonical PAR3 activation by factor Xa identifies a novel pathway for Tie2 activation and stabilization of vascular integrity.

Authors:  Fabian Stavenuiter; Laurent O Mosnier
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

Review 4.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

5.  Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent.

Authors:  Ruchika Sharma; Amanda P Waller; Shipra Agrawal; Katelyn J Wolfgang; Hiep Luu; Khurrum Shahzad; Berend Isermann; William E Smoyer; Marvin T Nieman; Bryce A Kerlin
Journal:  J Am Soc Nephrol       Date:  2017-04-19       Impact factor: 10.121

Review 6.  Protease-activated receptors in hemostasis.

Authors:  Marvin T Nieman
Journal:  Blood       Date:  2016-04-28       Impact factor: 22.113

7.  Protease-Activated Receptor 1 Deletion Causes Enhanced Osteoclastogenesis in Response to Inflammatory Signals through a Notch2-Dependent Mechanism.

Authors:  Sandra Jastrzebski; Judith Kalinowski; Sehwan Mun; Bongjin Shin; Naga Suresh Adapala; Christian E Jacome-Galarza; Faryal Mirza; H Leonardo Aguila; Hicham Drissi; Archana Sanjay; Ernesto Canalis; Sun-Kyeong Lee; Joseph A Lorenzo
Journal:  J Immunol       Date:  2019-05-20       Impact factor: 5.422

Review 8.  The domino effect triggered by the tethered ligand of the protease activated receptors.

Authors:  Xu Han; Marvin T Nieman
Journal:  Thromb Res       Date:  2020-08-04       Impact factor: 3.944

9.  SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity.

Authors:  Naveen Gupta; Roland Liu; Stephanie Shin; Ranjeet Sinha; Joseph Pogliano; Kit Pogliano; John H Griffin; Victor Nizet; Ross Corriden
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

Review 10.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.